RFX1 and colorectal cancer: Specifically, establishing RFX1 knockdown or overexpression models in colorectal cancer cell lines, followed by co-culture with immune cells such as CD8+ T cells or macrophages and performing immune phenotyping, could help clarify its regulatory effects on immune cell recruitment and activation.